SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-025789
Filing Date
2021-02-19
Accepted
2021-02-19 16:35:25
Documents
1
Group Members
5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM PARTNERS VI, LLCANDREW J. SCHWABDR. KUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SC 13D a21-7252_1sc13d.htm SC 13D 267387
  Complete submission text file 0001104659-21-025789.txt   269079
Mailing Address 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 350 SAN FRANCISCO CA 94107 415-993-8570
5AM Ventures VI, L.P. (Filed by) CIK: 0001753037 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Subject) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92269 | Film No.: 21656460
SIC: 2836 Biological Products, (No Diagnostic Substances)